Increasing Access to Hepatitis C Treatment in Opioid Endemic Rural Areas: the Kentucky Viral Hepatitis Treatment (KeY Treat) Study

增加阿片类药物流行的农村地区获得丙型肝炎治疗的机会:肯塔基州病毒性肝炎治疗 (KeY Treat) 研究

基本信息

  • 批准号:
    9793998
  • 负责人:
  • 金额:
    $ 225.51万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-09-30 至 2024-07-31
  • 项目状态:
    已结题

项目摘要

ABSTRACT The overarching goal of the Kentucky Viral Hepatitis Treatment Project (KeY Treat) is to increase access to treatment for the hepatitis C virus (HCV) in a rural Appalachian community in the midst of the opioid/HCV syndemic. This study seeks to examine whether removing barriers associated with accessing direct-acting antivirals (DAAs) for the treatment of HCV (high out-of-pocket costs, insurance restrictions requiring a specialist, abstinence, and significant liver damage) will significantly reduce the burden of HCV in Perry County, Kentucky. The proposed study is made possible by a significant drug donation from Gilead Sciences for sofosbuvir/velpatasvir, a 12-week, once per day, pan-genotypic DAA. KeY Treat proposes a multi-pronged approach to treating HCV using a mid-level provider model. In addition to DAA treatment, participants will be offered access to subsidized medication-assisted treatment, syringe services, and case management. We will leverage existing resources in the target community (public health, jail, hospital), as well as ongoing projects dedicated to increasing access to HCV care in affected communities (ECHO, FOCUS) to answer whether removing the major barriers to HCV treatment affect access, and what barriers remain. All RNA-positive residents of Perry County, Kentucky will be eligible/recruited for study participation (N≈900), and the following specific aims will be addressed: 1) determination of HCV treatment uptake among rural residents with chronic HCV; 2) examination of the predictors of treatment completion among those enrolled in KeY Treat; 3) examination of the characteristics of participants achieving sustained virologic response (SVR, or cure); 4) establishment of long-term re-infection rates among those achieving SVR; 5) examination of 5-year reductions in incidence and prevalence of HCV in the intervention community compared with a control county in rural Kentucky; and 6) evaluate the impact and cost-effectiveness of KeY Treat using mathematical modeling. The proposed research has tremendous potential to impact public health in the rural United States. The majority of counties identified in CDC’s recent HCV/HIV hotspot analysis were rural, and there is a real need to improve access to DAAs in order to prevent further HCV transmission, reduce the burden of advanced liver disease, and hepatocellular carcinoma in generations to come. Data from KeY Treat will inform policies around Medicaid/insurance restrictions for DAAs, and will deliver a much needed blueprint for the provision of HCV treatment in resource-deprived rural areas.
摘要 肯塔基州病毒性肝炎治疗项目(KeY Treat)的总体目标是增加获得 在阿片类药物/HCV中间的阿巴拉契亚农村社区治疗丙型肝炎病毒(HCV) 共病的本研究旨在探讨是否消除障碍与获得直接作用 治疗HCV的抗病毒药物(DAA)(自付费用高,保险限制要求 专家,禁欲,和严重的肝损伤)将显着降低佩里的HCV负担 县,肯塔基州。这项拟议的研究是由吉利德科学公司捐赠的大量药物促成的 对于索非布韦/维帕他韦,为期12周,每天一次,泛基因型DAA。KeY Treat提出了一个多管齐下的 使用中级提供者模式治疗HCV的方法。除了DAA治疗,参与者将 提供获得补贴的药物辅助治疗、注射器服务和病例管理的机会。我们将 利用目标社区(公共卫生、监狱、医院)的现有资源以及正在进行的项目 致力于增加受影响社区获得HCV护理的机会(ECHO,FOCUS),以回答是否 消除影响获得HCV治疗的主要障碍,以及仍然存在的障碍。所有RNA阳性 肯塔基州佩里县的居民将有资格/招募参加研究(N = 900),以及以下人员 具体目标将被解决:1)确定慢性丙型肝炎的农村居民中的HCV治疗吸收 HCV; 2)在参加KeY Treat的患者中检查治疗完成的预测因素; 3) 检查实现持续病毒学应答(SVR或治愈)的参与者的特征; 4) 在达到SVR的患者中确定长期再感染率; 5)检查5年减少率 干预社区与农村对照县HCV感染率和流行率的比较 肯塔基州;以及6)使用数学建模评估KeY Treat的影响和成本效益。的 拟议的研究有巨大的潜力影响美国农村的公共卫生。大多数 在CDC最近的HCV/HIV热点分析中确定的县是农村,并且有真实的需要改善 获得DAA,以防止进一步的HCV传播,减轻晚期肝病的负担, 和肝细胞癌的风险。来自KeY Treat的数据将为政策提供信息, DAA的医疗补助/保险限制,并将提供急需的HCV提供蓝图 在资源匮乏的农村地区的治疗。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jennifer R Havens其他文献

Jennifer R Havens的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jennifer R Havens', 18)}}的其他基金

Increasing Access to Hepatitis C Treatment in Opioid Endemic Rural Areas: the Kentucky Viral Hepatitis Treatment (KeY Treat) Study
增加阿片类药物流行的农村地区获得丙型肝炎治疗的机会:肯塔基州病毒性肝炎治疗 (KeY Treat) 研究
  • 批准号:
    10671703
  • 财政年份:
    2018
  • 资助金额:
    $ 225.51万
  • 项目类别:
Increasing Access to Hepatitis C Treatment in Opioid Endemic Rural Areas: the Kentucky Viral Hepatitis Treatment (KeY Treat) Study
增加阿片类药物流行的农村地区获得丙型肝炎治疗的机会:肯塔基州病毒性肝炎治疗 (KeY Treat) 研究
  • 批准号:
    9986734
  • 财政年份:
    2018
  • 资助金额:
    $ 225.51万
  • 项目类别:
Increasing Access to Hepatitis C Treatment in Opioid Endemic Rural Areas: the Kentucky Viral Hepatitis Treatment (KeY Treat) Study
增加阿片类药物流行的农村地区获得丙型肝炎治疗的机会:肯塔基州病毒性肝炎治疗 (KeY Treat) 研究
  • 批准号:
    10456003
  • 财政年份:
    2018
  • 资助金额:
    $ 225.51万
  • 项目类别:
Effect of structural interventions on substance use and HIV/HCV risk among rural PWUD
结构性干预措施对农村残疾人药物使用和 HIV/HCV 风险的影响
  • 批准号:
    9526110
  • 财政年份:
    2017
  • 资助金额:
    $ 225.51万
  • 项目类别:
Epidemiologic Study of the Effectiveness of an ADF in Reducing Opioid Abuse
ADF 减少阿片类药物滥用有效性的流行病学研究
  • 批准号:
    8529480
  • 财政年份:
    2012
  • 资助金额:
    $ 225.51万
  • 项目类别:
Effect of structural interventions on substance use and HIV/HCV risk among rural PWUD
结构性干预措施对农村残疾人药物使用和 HIV/HCV 风险的影响
  • 批准号:
    10058267
  • 财政年份:
    2012
  • 资助金额:
    $ 225.51万
  • 项目类别:
Assessing Care in the Context of an HIV Outbreak among PWID in Appalachia
评估阿巴拉契亚地区吸毒者艾滋病毒爆发背景下的护理
  • 批准号:
    10239310
  • 财政年份:
    2012
  • 资助金额:
    $ 225.51万
  • 项目类别:
Epidemiologic Study of the Effectiveness of an ADF in Reducing Opioid Abuse
ADF 减少阿片类药物滥用有效性的流行病学研究
  • 批准号:
    8723796
  • 财政年份:
    2012
  • 资助金额:
    $ 225.51万
  • 项目类别:
Epidemiologic Study of the Effectiveness of an ADF in Reducing Opioid Abuse
ADF 减少阿片类药物滥用有效性的流行病学研究
  • 批准号:
    8411011
  • 财政年份:
    2012
  • 资助金额:
    $ 225.51万
  • 项目类别:
Effect of structural interventions on substance use and HIV/HCV risk among rural PWUD
结构性干预措施对农村残疾人药物使用和 HIV/HCV 风险的影响
  • 批准号:
    9452026
  • 财政年份:
    2012
  • 资助金额:
    $ 225.51万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 225.51万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 225.51万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 225.51万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 225.51万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 225.51万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 225.51万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 225.51万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 225.51万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 225.51万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 225.51万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了